Local health officials in Hawaii confirmed 182 reported cases of dengue fever- the state’s largest dengue outbreak since World War II.
Newly-developed dengue vaccine by French drug firm Sanofi Pasteur (Sanofi SA’s vaccine division) receives a green light from Brazilian authorities following earlier regulatory approvals by Philippines and Mexico.
More details from four of the nine trials revealed that the drug, alirocumab manufactured by Sanofi and Regeneron might be able to cut the number of heart attack and stroke cases.
Sanofi and Regeneron's cholesterol drug reduced bad cholesterol levels in nine late-stage trials.
Researchers reported that an early trial testing the dengue fever vaccine shows promise.
Sanofi announced that its dengue fever vaccine was promising in a late-stage trial.
The U.S. FDA rejected Lemtrada, Sanofi's newest drug treatment for multiple sclerosis.
Lyxumia is an injectable drug manufactured by Sanofi, a French pharmaceutical company, to treat type 2 diabetes.